skip to main content

Hydroxychloroquine monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsHydroxychloroquine monitoringGPhC CRA

A patient starting hydroxychloroquine for lupus asks about eye safety. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Baseline and ongoing retinal screening according to specialist guidance

Hydroxychloroquine can cause retinal toxicity, particularly with long-term use and higher cumulative exposure. Patients require eye screening according to specialist or national guidance and should report visual changes. The other monitoring tests are not relevant.

Reference: BNF